Premium
Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: a randomized clinical trial, posttreatment outcomes, and six‐month follow‐up
Author(s) -
David Daniel,
Szentagotai Aurora,
Lupu Viorel,
Cosman Doina
Publication year - 2008
Publication title -
journal of clinical psychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.124
H-Index - 119
eISSN - 1097-4679
pISSN - 0021-9762
DOI - 10.1002/jclp.20487
Subject(s) - hamilton rating scale for depression , psychology , pharmacotherapy , fluoxetine , rational emotive behavior therapy , randomized controlled trial , beck depression inventory , cognitive therapy , rating scale , major depressive disorder , behaviour therapy , depression (economics) , psychiatry , clinical psychology , cognition , medicine , anxiety , developmental psychology , receptor , serotonin , economics , macroeconomics
A randomized clinical trial was undertaken to investigate the relative efficacy of rational‐emotive behavior therapy (REBT), cognitive therapy (CT), and pharmacotherapy in the treatment of 170 outpatients with nonpsychotic major depressive disorder. The patients were randomly assigned to one of the following: 14 weeks of REBT, 14 weeks of CT, or 14 weeks of pharmacotherapy (fluoxetine). The outcome measures used were the Hamilton Rating Scale for Depression and the Beck Depression Inventory. No differences among treatment conditions at posttest were observed. A larger effect of REBT (significant) and CT (nonsignificant) over pharmacotherapy at 6 months follow‐up was noted on the Hamilton Rating Scale for Depression only. © 2008 Wiley Periodicals, Inc. J Clin Psychol 64:728‐746, 2008.